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Background: The use of HDR in the treatment of soft tissue sarcoma had been on the rise.
However, there was limited study to evaluate the effect of different fractionation schemes
on soft tissue and the optimal HDR scheme.
Aims: We aimed to assess the histopathologic changes on soft tissue after different HDR
brachytherapy doses.
Methods: The subjects were divided into three groups. Each group included 10 limbs. Group A
hadonly an applicatorwithout radiation, groupB received a total of 24Gy at 6Gyper fraction,
twice a day, and group C received a total of 13.5Gy in a single fraction. The histopathologic
ﬁndingswere grouped into soft tissue pathology-1 (edema, inﬂammation, endothelial prolif-
eration, necrosis) and soft tissue pathology-2 (atrophy, calciﬁcation, vascular hyalinization,
ﬁbrosis) (STP-1–2).
Results: The highest mean grade values of STP-1 and STP-2 were observed in group C (0.95
and 1.45) in comparison to group A (0.45 and 0.85) and group B (0.65 and 0.9). The difference
in STP-1 was found signiﬁcant only between groups A and C and the difference in STP-2 was
found both between groups A and C and groups B and C.Conclusion: In our experimental study it was shown that the fractionated interstitial HDR
had both lower rate and severity of toxicity in comparison to a single high dose fraction.
Before using a single fractionated regimen in the clinic, the increased morbidity related to
the irreversible early toxicities or progressive late toxicities should be kept in mind.© 2010 Greater Poland
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1. Introduction
In recent years, the tissue damage caused by irradiation has
been explained by three mechanisms. First one is a well-
known phenomena characterized by a direct injury with the
mitotic death of parenchymal cells. The second one is cur-
rently accepted as themainmechanismand explains the early
and late responses of losing theparenchymal and stromal cells
after microvasculature injury.1,2 Furthermore, there is a new
paradigm that explains the third mechanism by the active bio-
logic response to radiation in normal tissues with the release
of cytokines, growth factors and chemokines.2–4 Nevertheless,
the time and dose of radiotherapywith a fractionation scheme
are as important as molecular and cellular changes in normal
tissue induced by radiation.2 All thesemechanisms are related
with each other and affect the severity of early and late toxic-
ity which limits the deliverable curative dose of radiotherapy
(RT), and might affect the life quality of the patient.
Although many different dose and fractionation schedules
have been improved until today, the conventional frac-
tionation regimen (1.8–2Gy/once a day) has been preferred
frequently for curative treatment of the most solid tumors.5,6
The reason being that better local control rates with fewer
toxicity incidences are obtained by a conventional regimen in
comparison to altered schemes. However, the application of
the conventional regimen to the radioresistant tumors such
as malign melanoma or soft tissue sarcoma may be a detri-
mental for treatment success. It was reported that better
treatment results are achieved in hypofractionated scheme
in curative treatment or single fraction scheme in palliative
treatment of soft tissue.5,7–10 Moreover, in recent years, it
has been shown that higher local control rates in soft tis-
sue sarcomas have been provided by intraoperative11,12 or
postoperative.13–15 High dose rate (HDR) brachytherapy with
hypofractionated schemes in single/multiple fractions. The
acceptable toxicity for different dose-fraction schemes ofHDR,
such as 15Gy in a single fraction or 36–50Gy in multiple frac-
tions, was reported.13
The lower rate of toxicity may be the result of the applica-
tion of high dose radiation to the limited therapy areas rather
than external RT. One of the major advantages of brachyther-
apy is that it can lead to dose optimization. In this process,
the isodose volumes in the tissue can be created by a combi-
nation of careful placement of catheter and the adjustment of
dwell times of a computerized stepping source.16 However, the
disadvantage is that the dose distribution is inhomogeneous
since the dose fall off is very rapid. This can result in increased
morbidity if hot spots occurring within critical normal tissues.
The dose inhomogeneity can be minimized, but not elimi-
nated, by optimizing the dwell times in HDR.17 Therefore, it
is not possible to estimate the severity of early and late reac-
tions in adjacent normal tissue that are exposed to high dose
radiation. Also, the high dose regions of the implant have a
large number of normal cells which consequently may lead to
severe normal tissue complications.18 Additionally, the sever-
ity of side effects can be increased by different fractionated
regimens of HDR.
In the light of radiobiologic knowledge, we know the effects
of radiation on soft tissue. But there is no experimental studyiotherapy 1 5 ( 2 0 1 0 ) 165–171
or prospective randomized clinical trial that evaluated thenor-
mal tissue damage of different dose-fractionation HDR which
notably is the current treatment modality for soft tissue sar-
coma. The trials in the literature are retrospectivewith limited
number of patients and the heterogeneous therapies applied.
This fact led us to evaluate the histopathologic changes on
soft tissue of a rabbit extremity after different HDR doses both
in a single and multiple fractionation schemes.
2. Materials and methods
The experimental protocol was approved by Gazi University
School of Medicine Experimental Animals Ethic Committee by
decisionnumber of G.U.ET-05.038. The experimentwas carried
out in compliance with the 3R (reduction, replacement, reﬁne-
ment) ethical guidelines. During the study, the animals were
being housed in the Animal Breeding and Research Laboratory
of Gazi University School of Medicine, at a constant temper-
ature (22±1 ◦C) and were bred with standard feed. The study
was conducted at Gazi University, Department of Radiation
Oncology.
The rabbits were preferred as subjects as suggested by the
literature in which the soft tissue damage of radiation was
assessed.19–22 A total of 10 New Zealand rabbits (male, 1500 g
on average, 2 months old) were used. It was planned to use
three extremities of each animal. The same extremities were
used for a particular treatment group in each animal. Each
group included 10 extremities. It was planned that the ﬁrst
group (groupA-right fore-limb) had only an applicatorwithout
radiation, the second group (group B-right hind-limb) received
a total of 24Gy at 6Gy per fraction, twice a day, and the third
group (group C-left hind-limb) received a total of 13.5Gy in
single fraction. To evaluate the variation in the effectiveness
of different fractionation doses and to compare the two treat-
ment regimens radiobiologically, the following formula was
used:
Dr/Dx = ˛/ˇ + dx/˛/ˇ + dr
[Dr: known total dose (referencedose), Dx: new total dose (with
different fractionation schedule), dr: known fractionation (ref-
erence), dx: new fractionation schedule].23
The ˛/ˇ ratio was accepted as 3.5 due to muscular, connec-
tive and vascular tissues involved in late reacting tissues.24
According to this formula, 13.5Gy, 24Gy, 13.5Gy and 6Gy
were determined for Dr, Dx, dr and dx, consecutively. After
calculation, it was shown that the effectiveness of 13.5Gy in
a single dose fraction was equal to 24Gy in 6Gy per fraction
radiobiologically (229.5≈228).
The animals were anesthetized with an intramuscular
injectionof xylazineHCl at a dose of 5mg/kg andketamineHCl
at a dose of 50mg/kg, prior to catheterization and brachyther-
apy.
For brachytherapy, a HDR afterloading system (Nucletron,
Holland) was used. After anesthesia, under sterile conditions,
through- and- through implant technique was used. The steel
guide needle was inserted through the extremity. The leader
(tapered end) of the ﬂexible nylon catheter (5 French in diam-
eter, 30 cm in length) was passed down the needle and both
the needle and catheter were pulled through the other end.
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A, 0.9±0.21 (minimum–maximum 0.75–1.25) in group B and
1.45±0.45 (minimum–maximum 0.75–2) in group C. In com-
parison of mean values between study groups, the signiﬁcant
difference was found both between groups A and C (p=0.021)
Table 2 – The frequencies of STP grades in study groups.reports of practical oncology and
fter the needle was removed, the catheter was pulled until
he closed end of it topped with a nylon button was in con-
act with the surface. Another nylon button was inserted at
he opposite end of the catheter and was cut at 3 cm from the
urface. The entry and exit sites of the catheter were marked
ith Indian ink.
After marking, a dummy wire was placed inside. Before
lanning, the simulation ﬁlms of all extremities of animals
ere taken at 30 and 330 gantry degrees to determine the
ource localization. The second, third and fourth catheter
oints, which indicate the soft tissue, were selected as refer-
nce. In the treatment planning system, the planning (with
–y–z coordinates) were performed for the application of
rachytherapy at a dose of 13.5Gy for group C and 6Gy for
roup B. It was planned to irradiate the same tissue volume
iving thedetermineddose to 1 cmaway fromthe source.After
he dummy wire was removed, the Iridium 192 wire (dose rate
as 15.69Gy/h) was inserted into the catheter with after load-
ng remote control system and the subjects were irradiated.
or group B, at least 6-h interval between the fractions was
llowed to let the sublethal damage repair on normal tissue.
Before sacriﬁcing, the differences in skin and hair, and
he presence of necrosis, and the function of extremity were
valuated once a week after brachytherapy. The animal was
nesthetized and sacriﬁced by intramuscular xylazine HCl
0mg/kg and ketamine HCl 200mg/kg, at the end of the 4th
eek following brachytherapy. All the three extremities were
emoved from the rabbit and put into caps with 10% forma-
in. Each cap was numbered from 1 to 30 and sent to Gazi
niversity Pathology Department.
For histologic examination, a thick tissue between the
pplicator entry and exit sitesmarked by a tattoowas removed
rom the extremity. Two transverse sections of thick tissue,
ncluding one from medial and lateral axis which are 1 cm
way from the central axis (source axis) – which predicted the
issue that received the determined dose – were obtained and
mbedded in parafﬁn. Five-micron thick tissue sections were
rovided and stained with Hematoxylin–Eosin. Each section
as assessed by a pathologist who was blinded to study the
roups. He evaluated the specimens for edema, inﬂammation,
ndothelial proliferation, muscle degeneration, atrophy, calci-
cation and ﬁbrosis. The scoring system described by Baker
nd Leith25 was used. According to the scoring system, ﬁve
rades were used. The grading was determined by assessing
he percentage of lesion in a slice. A detailed description of
rades is shown in Table 1. After the determination of grad-
ng scores in two sections, the highest scoring value for each
xtremity was taken for statistical analysis.
Table 1 – Histopathologic grading system.
Grade 0 None Normal appearance
Grade 0.5 −/+ Characteristic lesion is seen but
cannot be differentiated deﬁnitely
Grade 1 + Minimal lesion is apparent (≤25 of the
slice)
Grade 2 ++ Moderate degree lesion (>25 to ≤50 of
the slice)
Grade 3 +++ Very severe reaction (>50 of the slice)therapy 1 5 ( 2 0 1 0 ) 165–171 167
Statistical analyses were performed with SPSS (Statistical
Package for Social Sciences) 13.0 version. The 2 and Fischer
Exact tests were used to compare the qualitative data and
Mann–Whitney U test was used to compare the mean values
of quantitative data. The mean values were given with stan-
dard variations and minimum–maximum ranges. p values of
<0.05 were considered to be signiﬁcant.
3. Results
At physical examination, no neurologic deﬁcit, loss of extrem-
ity function and death were observed. At the end of the 3th
week, the hair loss on 6 (60%) extremities in group B and 7
(70%) extremities in group C were noted.
At histopathologic evaluation, a total of 30 extremitieswere
assessed. The soft tissue pathologies (STP)were separated into
two groups such as STP-1 including edema, inﬂammation,
endothelial proliferation, necrosis; and STP-2 including atro-
phy, calciﬁcation, vascularhyalinizationandﬁbrosis.However,
as well as the acute reactions, the starting of histopathological
ﬁndings such as atrophy, calciﬁcation, vascular hyalinization
and ﬁbrosis at the end of the 4th week after radiation, which
was determined as latent period, led us to evaluate those as
the beginning of late histopathologic reactions.
The frequencies of STP grades in study groups were ana-
lyzed according to four grading scores (Grades 0, 1, 2, 3)
as no grade 0.5 STP was observed (Table 2). After that,
the mean values of STP grades were analyzed. For STP-
1, it was 0.45±0.23 (minimum–maximum 0.25–1) in group
A, 0.65±0.65 (minimum–maximum 0–1.75) in group B and
0.95±0.56 (minimum–maximum 0.25–1.75) in group C. In
comparison of the mean values between study groups, the
signiﬁcant difference was found only between group A and
C (p=0.041). The differences between group A and B or group
B and C were 0.617 and 0.222, respectively. For STP-2, the mean
value was 0.85±0.56 (minimum–maximum 0.25–1.5) in groupStudy groups
Group A
(n=10)
Group B
(n=10)
Group C
(n=10)
STP-1
Grade 0 – 4 –
Grade 1 9 2 6
Grade 2 1 2 2
Grade 3 – 2 2
STP-2
Grade 0 – – –
Grade 1 6 4 2
Grade 2 4 6 4
Grade 3 – – 4
STP: soft tissue pathologies; group A: control arm; group B: fraction-
ated HDR arm; group C: single fractionated HDR arm.
168 reports of practical oncology and radiotherapy 1 5 ( 2 0 1 0 ) 165–171Fig. 1 – The irregular shape and diameter of vessels,
HE×400.
and groups B and C (p=0.008). The difference between groups
A and B was not found signiﬁcant.After evaluation of STP-1 and STP-2 values with the quartet
scoring system, two subgroups of STPs, low grade (grades 0, 1)
and high grade (grades 2, 3), were constituted. In comparing
the distribution of low andhigh grades of STP-1 between study
Table 3 – The distribution of low and high grade of soft tissue p
Study groups
A (n =10) B (n =10) p A (n =10)
STP-1
Edema
LG 8 4 0.085 8
HG 2 6 2
Inﬂammation
LG 2 6 0.085 2
HG 8 4 8
Endothelial proliferation
LG 10 6 0.043* 10
HG – 4 –
Necrosis
LG 9 7 0.291 9
HG 1 3 1
STP-2
Muscle atrophy and deformation
LG 9 4 0.029* 9
HG 1 6 1
Calciﬁcation
LG 6 4 0.328 6
HG 4 6 4
Vascular hyalinization
LG 10 10 – 10
HG – – –
Fibrosis
LG 7 7 0.686 7
HG 3 3 3
STP: soft tissue pathologies; group A: control arm; group B: fractionated
high grade.
∗ p≤0.05, as statistically signiﬁcant.Fig. 2 – The ﬁbrin accumulation, necrosis and calciﬁcation
in vessel wall, HE×40.
arms, the endothelial proliferation (p=0.043) between groups
A and B; the edema (p=0.012), the endothelial proliferation
(p=0.005), the necrosis (p=0.003) between groups A and C; and
the necrosis (p=0.035) between groups B and C were found
signiﬁcant (Table 3). In Fig. 1, the irregular shape and diameter
of vessels and endothelial proliferation, in Fig. 2 the necrosis
athologies among study groups.
C (n =10) p B (n =10) C (n =10) p
2 0.012* 4 2 0.314
8 6 8
2 0.709 4 2 0.085
8 6 8
4 0.005* 6 4 0.371
6 4 6
2 0.003* 7 2 0.035*
8 3 8
– 0.000* 4 – 0.043*
10 6 10
2 0.085 4 2 0.314
8 6 8
6 0.043* 10 6 0.043*
4 – 4
2 0.035* 7 2 0.035*
8 3 8
HDR arm; group C: single fractionated HDR arm; LG: low grade; HG:
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n vessel wall and in Fig. 3 the necrosis in muscle was shown.
For STP-2, the differences of muscle atrophy and deforma-
ion (p=0.029) between groups A and B; muscle atrophy and
eformation (p=0.000), vascular hyalinization (p=0.043) and
he ﬁbrosis (p=0.035) between groups A and C; muscle atrophy
nd deformation (p=0.043), vascular hyalinization (p=0.043)
nd ﬁbrosis (p=0.035) between groups B and C were found sig-
iﬁcant (Table 3). In Fig. 2, the calciﬁcation of vessel wall and
n Fig. 4, the atrophy and ﬁbrosis of muscle were shown.
. Discussion
he soft tissue damage after external radiotherapy or
rachytherapy,which is not frequently seen aswell asmucosi-
is or enteritis, cause serious effects. The incidence of soft
issue damage according to various treatment schemes is
eported as 0–40%.26 It is frequently seen after breast and head
nd neck cancer or soft tissue sarcomas. Although the high
ocal control rates for soft tissue sarcomas after wide local
xcision and RT are reported,27 the increased morbidity of
Fig. 4 – Atrophy and ﬁbrosis of the muscle, HE×200.therapy 1 5 ( 2 0 1 0 ) 165–171 169
wide area radiation after surgery limits the effectiveness of
the therapy. For this reason, in recent years, most clinicians
have preferred brachytherapy applied on a limited area with-
out external RT.13 However, there is no consensus for optimal
dose and fractionation scheme of brachytherapy. In retrospec-
tive series, frequently preferred HDR schemes after external
RT (45–50Gy)were 15–25Gy in a single ormultiple fraction.13,28
If HDR is used alone, 42–45Gy at 4–6 fractions or 36Gy in
10 fractions, twice a day, are recommended.13 For pediatric
patients, the recommended postoperative HDR dose without
external radiation is 36Gy (in 12 fractions, twice a day), which
is lower than that for adults’,28,29 and the intraoperative HDR
after external RT was applied at a dose of 12–15Gy in a single
fraction for this group.29
In our study, the intended doses to evaluate were chosen
considering frequently applied treatment schemes of 36Gy in
12 fractions and single dose between 12 and 15Gy to pediatric
patients who are under higher risk of delayed side effects due
to longer life expectancy. To assess the variation in the effec-
tiveness of fractionation doses and to compare the treatment
regimens radiobiologically, the formula which was mentioned
before was used. According to the formula, when alpha beta
ratio was accepted as 3.5Gy, the radiobiological approximate
value of 36Gy in 12 fractions was 13.5Gy in a single frac-
tion (234≈229.5). Since we think it would cause a heavier side
effect due to larger fraction size,wewanted to compare amore
hypofractionated regimen than that of 36Gy with 3Gy daily
fraction dose to 13.5Gy in a single fraction. Therefore, it was
determined to apply 24Gywith 6Gy fraction size, in 4 fractions
twice a day, after it had been shown to be nearly equal to that
of 13.5Gy (228≈229.5).
Radiation effects on normal tissue are usually divided into
two categories, namely early and late reactions. It is impor-
tant to determine the difference between those for clinical
presentation of treatment-related morbidity.30 The morbid-
ity that occurs within 90 days, typically 3–9 weeks after the
start of RT has been deﬁned as an early reaction; and the reac-
tion that occurs after 90 days of radiation has been deﬁned
as late reaction; however, greater damage leads to a shorter
latent period.31 While cell loss and limited repopulating activ-
ity play major roles in the development of side effects, both
acute and late, cascades of inﬂammatory and ﬁbrogeneic cyto-
kenes starting immediately after irradiation have also been
identiﬁed. These events occur during the clinically silent, so-
called latent period, and this period, before the late effects
become apparent, is not biologically silent, as it is the time
when cytokine cascades lead to the progressive tissue changes
such as ﬁbrosis.32 Furthermore, it was shown in the study of
Sener et al., that collagen contents of the studied tissues of
rats after whole body irradiation were signiﬁcantly increased
72h following irradiation, despite the application of protec-
tive agent (Ginkgo biloba extract), indicating the presence of
tissue ﬁbrotic activity.33 So, it is not a surprise to see late
reactions such as ﬁbrosis, histopathologically, at the end of
the 4th week after brachytherapy as seen in our study. If
the late reactions such as ﬁbrosis are considered to have
a tendency of being a progressive and irreversible process,
it is certain that the ever-increasing evidence of ﬁbrosis in
histopathologic evaluation will become apparent in clinic in
the following years. And it gives clinicians a message about
d rad
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the rate and the severity of side effects which can increase
consequently.
In general, the increased permeability in small blood
vessels and the endothelial proliferation in large vessels
are observed after ﬁrst fraction of RT.34 The increased per-
meability causes edema and inﬂammation in reaction to
leukocytes’ immigration to thedamaged tissue and the release
of cytokines.35 As well as vascular changes, necrosis can also
be seen after higher doses of above 10Gy in an early period.36
Therefore, in our study the histopathologic ﬁndings, such as
edema, inﬂammation, endothelial proliferation and necro-
sis, were included in the STP-1 group which represents early
reactions. After analyzing the distribution of the mean STP-
1 grades in the groups, the highest values were observed in
the single fraction HDR group (sHDR=group C) and the low-
est values were observed in the control group (group A). In
comparison of the mean values between study groups, the
signiﬁcant difference was only found between the control and
sHDR groups. It can be explained by the fact that the appli-
cation of a single fraction (single hit theory) in high dose
causes a death of great number of parenchymal cells (the
alpha component of linear quadratic model). If the radiation
dose, especially the fraction dose, is increased, mitotic death
occurs both in mature cells and limited proliferable soft tis-
sue cells.9,37 Since the remaining cells proliferate partially, the
high ratio of parencymal cell loss cannot be compensated and
the more intense acute reactions occur, such as the observed
diffuse necrosis in the sHDR group. Also it supports the corre-
lation between increasednecrosis ratio andhighdoses. During
the application of high doses in a single fraction, it should
be remembered that the necrosis is irreversible and it may
increase the severity ofmorbidity both in early and late period.
When the distributions of low and high grades of STP-1
between the groups were compared, the difference between
control and fractionated HDR (fHDR) groups for endothelial
proliferation and the difference between the control and sHDR
groups for edema, endothelial proliferation and necrosis were
found signiﬁcant. No observation of evident toxicity in the
fHDR group may be the reason for applying a total dose in frac-
tions (multi-hit theory) and allowing a tissue repair between
the fractions. Besides, the type and the kinetic of tissue play a
major role in the development of early reactions rather than
the fraction size and total dose.9,37 The early effects of radia-
tion are observed in rapidly proliferating tissues (skin,mucosa,
intestinal epithelium, etc.) due to their high radiosensitivity in
comparison to the slow proliferating tissues, such as the soft
tissue, which show resistance to radiation.5 No observation
of signiﬁcant difference in early reaction between control and
fHDR groups supports this theory.
The tissue damage in early period is usually transient and
frequently recovered. However, in tissue with low regener-
ation capacity, the acute inﬂammation can be healed with
scar.35 On the other hand, the vascular damage and cytokine
release play a role in the development of scar and ﬁbrosis.
Many cytokines and growth factors are released by increasing
inﬂammatory cells owing to increased vascular permeabil-
ity. The chemokines activate the synthesis of extracellular
matrix which starts the process of ﬁbrosis.2–4 Also, the radi-
ation injury to the endothelial cells induces the proliferative
activity. After a while, the generation of capillaries of irreg-iotherapy 1 5 ( 2 0 1 0 ) 165–171
ular diameter and shape is seen (Fig. 1).38 The thrombosis
is observed owing to the narrow portion of these capillar-
ies easily occluded by cells, and after that, the necrosis is
observed at vessel walls (Fig. 2). The damage of the vessels
impoverishes the nutritional quality of the extracellular ﬂuid,
ultimately leading to the loss of parenchymal cells and an
increase in ﬁbroblasts, and then ﬁbrosis takes the place of
dead cells (Figure 4).34,39 Moreover as a result of tissue dam-
age, the calciﬁcation can be seen in both vascular structures
and parenchyma (Fig. 2). Since these ﬁndings are observed
at the late period after radiation30,35,40 and the processes in
the development phases get along with our histopathologic
ﬁndings, the atrophy, calciﬁcation, vascular hyalinization (col-
lagen accumulation) and ﬁbrosis were evaluated separately.
In the assessment of STP-2 grades in the groups, the ﬁndings
were more severe in the group of sHDR. It is known that the
early reactions are related to daily and weekly radiation dose
rather than the fraction size. However, the most important
parameters for the late reactions are fraction size and the time
interval between fractions.5,9,41 In our study, while no differ-
ence was found in comparison of the mean values of STP-1
grades among the irradiated groups, the signiﬁcant difference
was found in comparison of STP-2 grades. This result shows
the relation between the late effects and fraction dose. Also
the severity of reactions in the fHDR group is lesser than that
of the sHDRgroup andno evident difference between the fHDR
and control group supports the necessity for the application
of total doses in fractions and allowing at least 6-h interval
for sublethal damage repair. To conclude, while lowering the
fraction dose and allowing a deﬁnite time interval decrease
the severity of late reactions, it has no major effect on early
reactions.
5. Conclusion
Radiation related toxicity might negatively affect the tissue
and organ functions with long-term health-related life qual-
ity of the patient. The hazard of toxicities may be higher than
expected by the application of high doses of brachytherapy in
soft tissue sarcoma. Our study aimed to evaluate the effects of
different doses of interstitial HDR brachytherapy on soft tis-
sue histopathologically. Our ﬁndings veriﬁed that increased
rates and grades of side effects were observed in sHDR treat-
ment. Therefore, if the aim is to cure the patient, high doses
should be applied in multiple fractions with sufﬁcient time
interval. Otherwise, applying high doses in a single fraction
regimen, which has a high toxicity rate in late period in con-
trast to early period, should be preferred for patients with less
life expectancy. Before using this regimen as curative therapy
to the patients, especially to pediatrics, the increased mor-
bidity related to the irreversible toxicities such as necrosis or
ﬁbrosis should be kept in mind.
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